Safety Issues of New Anticoagulants
Mary Greeley Medical Center Grand Rounds is a multi-disciplinary clinical activity which serves to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public or the profession.
Physicians, mid-level providers, nurses and healthcare administrators.
- Understand the basic pathophysiology of newly available anticoagulant and reversal agents.
- Understand when to provide patients with these medications.
- Understand inherent risks and benefits on novel and new anticoagulant and reversal agents.
Jonathan Burns, DO
Emergency Medicine, McFarland Clinic
Joseph Merchant, MD
Hematology/Oncology, McFarland Clinic
- Dr. Burns and Dr. Merchant have nothing to disclose regarding financial relationships with any commercial entities, commercial companies providing support for this program, or any commercial manufacturers of products and/ or the providers of services discussed in this presentation.
- Dr. Brenda Burrough discloses she is a principal investigator in an Amgen research trial.
- No members of the Mary Greeley Medical Center CME Committee who planned this activity, including Dr. Burrough, have any financial relationship to disclose relating to the content.
The content and selection of speaker(s) is the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee.
Continuing Education Credit
- DO: Des Moines University is accredited by the American Osteopathic Association (AOA) and approves this live activity for 1.0 AOA Category 1-A CME credit(s).
- 1.00 AOA Category 1A